Security reports

Cyanotech cultivates and produces microalgae-based nutritional supplements at its facility in Hawaii. The company's primary products include BioAstin Hawaiian Astaxanthin and Hawaiian Spirulina, which are marketed for health and nutrition applications.

Cellectis is a clinical-stage biopharmaceutical company that develops allogeneic CAR T-cell immunotherapies for cancer treatment using its proprietary TALEN gene editing technology. The company creates off-the-shelf cellular therapies from healthy donor cells.

Atossa Genetics operates as a clinical-stage biopharmaceutical company focused on developing therapies for breast cancer and other breast health conditions. The company conducts research on therapeutic candidates and diagnostic technologies related to breast disease treatment and prevention.

FutureFuel provides custom toll manufacturing and specialty chemical synthesis services, producing organic chemicals for pharmaceutical, agricultural, coatings, and cleaning product applications. The company also manufactures biodiesel and markets performance chemicals under the FutureChem and FutureSol brands.

AGTC (now operating as Beacon Therapeutics) is a clinical-stage biotechnology company focused on developing gene therapies for ocular diseases. The company uses adeno-associated virus (AAV) gene therapy technology to treat rare and prevalent retinal conditions including X-linked retinitis pigmentosa, dry age-related macular degeneration, and cone rod dystrophy.

Zoetis develops and manufactures medicines, vaccines, diagnostics, and technologies for animal health across companion animals and livestock species. The company serves veterinarians, livestock producers, and pet owners in over 100 countries.

LyondellBasell manufactures chemicals, polymers, fuels, and advanced materials used in packaging, transportation, healthcare, and consumer goods applications. The company produces plastics, polymer solutions, and fuel ethers, and licenses chemical process technologies to the industry.

Pfizer is a biopharmaceutical company that discovers, develops, manufactures, and distributes prescription medicines and vaccines. The company focuses on therapeutic areas including oncology, internal medicine, inflammation and immunology, and rare diseases.

Cytori Therapeutics develops and manufactures medical devices focused on cell therapy and regenerative medicine applications. The company's technology processes adipose tissue to isolate and deliver cellular therapies for therapeutic use.

bluebird bio develops and commercializes gene therapies for rare genetic diseases. The company produces treatments for sickle cell disease, beta-thalassemia, and cerebral adrenoleukodystrophy using modified blood stem cells to address the underlying genetic causes of these conditions.

AMAG Pharmaceuticals was a specialty pharmaceutical company that focused on therapeutics for maternal health, anemia management, and other conditions. The company was acquired by Covis Pharma in 2020 and subsequently became part of Azurity Pharmaceuticals.

Acadia Pharmaceuticals develops and commercializes therapies for neurological disorders and rare diseases. The company focuses on conditions such as Parkinson's disease psychosis, Rett syndrome, and Alzheimer's disease psychosis.

Alexion develops and delivers therapeutic treatments for people living with rare diseases. The company focuses on research and development across multiple rare disease categories, including conditions affecting blood, cardiac, metabolic, and neurological systems.

Diplomat operates as an Icelandic business entity. Without available website content or additional public information, the specific nature of its products, services, or business operations cannot be determined.

AstraZeneca is a biopharmaceutical company that researches, develops, and manufactures prescription medicines across multiple therapy areas. The company's portfolio includes treatments for oncology, cardiovascular, renal, metabolic, and respiratory diseases.

DBV Technologies is a biopharmaceutical company focused on developing treatments for food allergies. The company's primary technology involves an epicutaneous immunotherapy platform that delivers allergen proteins through an adhesive patch applied to intact skin.

Dermira was a biopharmaceutical company focused on developing and commercializing therapies for dermatological conditions. The company specialized in treatments for medical dermatology, including hyperhidrosis and other skin disorders, before being acquired by Eli Lilly in 2020.

Celgene was a biopharmaceutical company that focused on developing and commercializing therapies for cancer and inflammatory diseases. The company was acquired by Bristol Myers Squibb in 2019 and now operates as part of that organization.

Aceto operates as a pharmaceutical and chemical company that sources, markets, and distributes finished dosage form generic drugs and active pharmaceutical ingredients. The company also provides specialty chemicals and intermediates for various industrial applications.

Waters manufactures and sells analytical instruments, software, and consumables for laboratory applications. The company provides liquid chromatography, mass spectrometry, and thermal analysis systems used in pharmaceutical development, food safety testing, and chemical research.

Cleveland BioLabs is a biopharmaceutical company that develops treatments for cancer and acute radiation syndrome. The company focuses on novel therapeutic approaches targeting radiation protection and oncology applications.

BiondVax operates as a clinical-stage biopharmaceutical company focused on developing universal influenza vaccines. The company's vaccine candidates are designed to provide protection against multiple strains of the flu virus through a single immunization.

Apricus Biosciences was a biopharmaceutical company focused on developing drug delivery systems and pharmaceutical products. The company merged with Seelos Therapeutics in 2019, with stockholders approving the transaction that year.

Neuralstem's website has been compromised and now displays content for an online gambling platform offering slot machine games and casino services. The domain originally belonged to a biotechnology company but currently hosts third-party gambling content in Thai language.

Cocrystal Pharma is a clinical-stage biotechnology company that develops antiviral therapeutics targeting viral replication processes. The company uses structure-based drug discovery methods to create treatments for influenza, norovirus, coronaviruses, and hepatitis C.

Constellation Pharmaceuticals was a biopharmaceutical company focused on developing and commercializing therapeutics targeting epigenetics, particularly for the treatment of cancer. The company was acquired by MorphoSys AG in 2021.

Clovis Oncology is a biopharmaceutical company focused on developing and commercializing cancer treatments. The company specializes in targeted therapies for various oncology indications, with a focus on precision medicine approaches to treating cancer patients.

Cidara Therapeutics develops targeted immunotherapies for serious diseases using its Cloudbreak platform technology. The company creates drug-Fc conjugate therapies that combine small molecules or peptides with human antibody fragments to inhibit disease targets while engaging the immune system.

BioMarin Pharmaceutical develops and commercializes therapies for rare genetic diseases, including treatments for achondroplasia, severe hemophilia A, and lysosomal storage disorders. The company currently markets eight commercial products and maintains a pipeline of clinical and preclinical drug candidates focused on genetically defined conditions.

Axovant Sciences was a clinical-stage biopharmaceutical company focused on developing treatments for neurological diseases, including dementia and movement disorders. The company pursued therapies targeting conditions such as Alzheimer's disease and Parkinson's disease through its drug development programs.

Aravive is a clinical-stage biopharmaceutical company focused on developing targeted therapeutics for cancer and other life-threatening diseases. The company's pipeline centers on protein-based drug candidates designed to inhibit specific biological pathways involved in tumor growth and metastasis.

Regeneron Pharmaceuticals is a biotechnology company that develops and manufactures prescription medicines for serious diseases. The company focuses on biologics and genetic medicines across therapeutic areas including oncology, immunology, and rare diseases.

Vertex Pharmaceuticals develops and commercializes prescription medications for the treatment of serious diseases. The company focuses primarily on cystic fibrosis therapies and has an expanding pipeline in other therapeutic areas including pain, kidney disease, and sickle cell disease.

Johnson & Johnson is a healthcare company that operates through two main divisions: Innovative Medicine and MedTech. The company develops pharmaceuticals for areas including oncology, immunology, neuroscience and cardiopulmonary conditions, as well as medical devices for cardiovascular, orthopedic, surgical and vision applications.

Gilead Sciences is a biopharmaceutical company that develops and commercializes prescription medicines for treating HIV, viral hepatitis, cancer, and inflammatory diseases. The company maintains a pipeline of clinical programs across virology, oncology, and inflammation therapeutic areas.

IDEXX develops and provides diagnostic products, software, and laboratory services for veterinary medicine. The company offers point-of-care diagnostic instruments, reference laboratory testing, practice management software, and continuing education resources for veterinary professionals.

Quest Diagnostics operates clinical laboratory testing services, performing diagnostic tests on patient specimens at locations across the United States. The company offers thousands of lab tests covering areas such as routine health screenings, genetic testing, drug monitoring, and disease detection for patients, healthcare providers, and organizations.

BioTime is a biotechnology company focused on developing and commercializing products in the field of regenerative medicine. The company works on cell-based therapies and research tools derived from pluripotent stem cells for treating degenerative diseases.

Amedica is a medical device company that develops and manufactures silicon nitride ceramic implants for spinal fusion procedures. The company's products are designed to provide an alternative to traditional metal and polymer-based spinal implant materials.

Merck & Co. is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines, vaccines, and animal health products. The company focuses on therapeutic areas including oncology, infectious diseases, immunology, and cardiovascular conditions.